PRTODAY / NewswireToday Free press release distribution service network

More news: Research
Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Recognizes QuantaLife's Innovative Technology for Enabling Advances in Biomedical Research, Diagnostics, and Personalized Medicine - Path Breaking ddPCR™ System Provides Even More Precise Measurements than Currently Used qPCR Methods
Frost & Sullivan Recognizes QuantaLife's Innovative Technology for Enabling Advances in Biomedical Research, Diagnostics, and Personalized Medicine

 

NewswireToday - /newswire/ - Mountain View, CA, United States, 2011/06/24 - Path Breaking ddPCR™ System Provides Even More Precise Measurements than Currently Used qPCR Methods.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent analysis of the personalized medicine market, Frost & Sullivan recognizes QuantaLife, Inc. with the 2011 North American Frost & Sullivan Award for New Product Innovation for its Droplet Digital™ Polymerase Chain Reaction (ddPCR™) system, a next generation of PCR that provides an absolute quantification measurement of nucleic acid molecules in nanoliter droplet form.

Real-time PCR has long been the gold standard for sensitive DNA quantification. With even greater sensitivity and precision, the ddPCR™ system is market-changing and has far-reaching applications in research and diagnostics. By allowing for detection at lower target levels, the ddPCR™ system has the ability to identify diseases earlier in progression, providing a major advantage for diagnostics and preventative medicine. Therefore, QuantaLife is poised to play a significant role in the development of companion diagnostics central to the emergence of personalized medicine.

"Essentially, this new technology provides even more precise measurements than the gold-standard qPCR methods widely used for fifteen years," says Frost & Sullivan Industry Analyst Christi Bird. "The unmatched resolution allows detection of target molecules at extremely low levels, which has major implications for not only precise life science research applications, but also early diagnosis of disease and development of accurate companion diagnostics for personalized healthcare."

Launched in November 2010, QuantaLife's ddPCR™ system consists of two separate instruments, the droplet generator and the droplet reader, both compact and sleek in design. The smaller of the two instruments, the droplet generator, divides each sample into 20,000 one-nanoliter droplets. After depositing the droplets into a 96-well plate, researchers then transfer the plate to their own standard thermal cyclers to amplify the targeted DNA/RNA molecules. Returned to QuantaLife's droplet reader instrument, droplets are streamed single file past a two color fluorescence detector and read as either positive or negative for the target DNA/RNA molecules. The platform then uses statistics to determine the concentration of the selected target in the original sample, thus providing a digital absolute quantification.

The ddPCR™ system provides several advantages over traditional real-time PCR. In particular, the system can better detect the difference between samples with similar genomic structures, a major advantage in determining copy number variation. This precise technology can also identify a +/-10 percent difference in gene expression between samples. Additionally, the instrument can detect a rare difference against a similar and common background.

"This advantage allows extremely sensitive detection of rare mutations when real-time PCR fails at certain concentration due to competitive amplification of the common DNA," says Bird. "The excitement this technology is already generating is evident from the hefty $17.2 million series B financing round the company received in December 2010."

Overall, QuantaLife exhibits the qualities necessary for an entrepreneurial company to succeed – dedication to innovation, a next-generation platform that significantly exceeds earlier technologies, and a solid plan for future growth. The ddPCR™ system has the ability to significantly improve PCR resolution, impacting a plethora of applications requiring precise measurements. Frost & Sullivan expects even greater innovations from this new company over the next few years as it ramps up commercialization of the ddPCR™ system, builds awareness, and pursues new markets. In recognition of its commitment to technology innovation and improving life sciences research and diagnostics, QuantaLife is the worthy recipient of the 2011 Frost & Sullivan Award for New Product Innovation Award in personalized medicine.

Each year, Frost & Sullivan presents this award to the company that that has developed an innovative element in a product by leverage leading edge technologies. The award recognizes the value added features/benefits of the product and the increased ROI it offers customers, which in turn increases customer acquisition and overall market penetration potential.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About QuantaLife, Inc.

QuantaLife, a venture-backed startup company based in Pleasanton, CA recently developed Droplet Digital™ Polymerase Chain Reaction (ddPCR™) technology, a next generation of PCR that provides an absolute quantification measurement of single molecules in nanoliter droplet form. The company was founded in August of 2008. After launching the ddPCR™ system in November 2010, the firm closed $17.2 million in Series B financing in December to accelerate application development for its platform and establish commercial operations in 2011.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Recognizes QuantaLife's Innovative Technology for Enabling Advances in Biomedical Research, Diagnostics, and Personalized Medicine

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Mireya Espinoza 
210-247-3870 mireya.espinoza[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Research Most Recent Related Newswires:

DSM-Niaga Ready for Commercial Scale Production of 100%-recyclable Carpets
DSM Dyneema Introduces Whole New Level of Cut Protection with Black Dyneema® Diamond Technology
DSM Presents Sustainable and Healthy Dairy Solutions At FoodTech 2016
Frost & Sullivan Highlights GENEWIZ's Commitment to Providing Cutting-edge Services in the Life Science Research Services Market
DSM to Present its Latest Advances in Skin Biochemistry At IFSCC Conference
DSM Launches ForTii® Ace Next Generation High Performance Polyamides
DSM Launches New Cultures to Reduce Cheese Ripening Time
DSM Launches New 3C Technology to Reinvigorate Omega-3 Supplements Category
DSM to Highlight its Health and Indulgence Solutions for Baked Goods At IBIE
DSM Welcomes EU Novel Foods Approval for Heart Health Antioxidant
DSM Dyneema Successfully Defends Key Patent Against Competitor Challenge
DSM Expands its Automotive Electronics Portfolio with High-flow Akulon PA66
BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions
BD Announces New Software Release for Pyxis Enterprise Solution
DSM Opens its Asia Pacific Personal Care Technical & Application Center in Shanghai

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)